Dark

TRDA
Entrada Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

May 7, 2026 3:59:50 PM EDT

6.90USD-56.956%(-9.13)4,126,696

0.00Bid 0.00Ask 0.00Spread

Pre-market

May 7, 2026 9:27:30 AM EDT

6.86USD-57.205%(-9.17)122,929

After-hours

May 7, 2026 4:54:30 PM EDT

6.90USD-0.012%(0.00)2,233

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

267.47M

Industry

Biotechnology

Next Earnings

May 14, 2026 (6d)

TRDA Stats

Avg. Vol. 10 Day

292,448

Avg. Vol. 30 Day

202,285

Employees

130

Market Cap

267,474,044

Shares Out.

38,820,616

On/Off Exchange

56%/44%

6 Month Beta

1.16

1 Year Beta

1.44

2 Year Beta

1.34

3 Year Beta

1.33

52 Week Low

4.93

52 Week High

16.45

SMA50

13.02

SMA200

9.31

1 Week

-48.96%

1 Month

-50.25%

3 Month

-35.00%

6 Month

-0.29%

1 Year

-15.56%

2 Year

-50.36%

5 Year

-71.23%

Profile

entrada therapeutics is building the leading intracellular biologics company to transform the treatment of devastating diseases. entrada was co-founded in 2016 by 5am ventures, a leading life sciences venture capital firm.

TRDA Stock Summary

Entrada Therapeutics, Inc. Common Stock (NASDAQ:TRDA) stock price today is $6.90, and today's volume is 4,126,696. TRDA is down -56.956% today. The 30 day average volume is 202,285. TRDA market cap is 267.47M with 38,820,616 shares outstanding.

.dark-mode .CBKqlJ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .CBKqlJ{ color: #333333; background-color: white; border: 2px solid #333333; }TRDAEntrada Therapeutics, Inc. Common Stockstock NASDAQ

TRDA Stock Summary

TRDA
Entrada Therapeutics, Inc. Common Stock
stock NASDAQ